Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

1(50.0%)

N/A

1(50.0%)

2Total

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04980443Not ApplicableCompleted

Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors

Role: collaborator

NCT05161130Completed

Predicting Outcomes After Lumbar Fusion for Degenerative Disease

Role: lead

NCT03822390Completed

Diagnostic Performance of a Convolutional Neural Network for Diminutive Colorectal Polyp Recognition

Role: collaborator

NCT04660656Unknown

Predictive Value of the Five-repetition Sit-to-stand Test After Lumbar Spine surgerySTS-3 Study.

Role: lead

NCT03321357Completed

Retest-reliability and At-home-assessment Feasibility of the 5R-STS

Role: lead

NCT01461785Phase 2Completed

The Use of Activated Platelet Rich Plasma (PRP) in Human Autologous Fat Transfer

Role: lead

All 6 trials loaded